Support By : Li-lab
| GENE_SYMBOL | DRUG_NAME | Ki (nM) | IC50 (nM) | Kd (nM) | EC50 (nM) | Potency (nM) | AC50 (nM) | Datasource |
|---|---|---|---|---|---|---|---|---|
| CYP2C19 | 5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one | NA | 147000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | 1-Methyl-6-pyridin-3-yl-3,4-dihydroquinolin-2(1H)-one | NA | 122000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | Carbamazepine | NA | NA | NA | NA | 100262 | NA | PubChem |
| CYP2C19 | 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester | NA | NA | NA | NA | 106301 | NA | PubChem |
| CYP2C19 | 3-(3-Methyl-1H-imidazol-4-yl)-pyridine | NA | 122100 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | Maleic Acid | NA | NA | NA | NA | 100262 | NA | PubChem |
| CYP2C19 | (+/-)-N-3-Benzylnirvanol | 250000 | NA | NA | NA | NA | NA | BindingDB |
| CYP2C19 | Sulfaphenazole | NA | 500000 | NA | NA | NA | NA | PubChem |
| CYP2C19 | Lysergide | NA | NA | NA | NA | 165305 | NA | PubChem |
| CYP2C19 | 3-(2-Thienyl)pyridine | NA | 178000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | 3-(3-Thienyl)pyridine | NA | 111200 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | Auglurant | NA | 106000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | D-Lactic Acid | NA | NA | NA | NA | 139962 | NA | PubChem |
| CYP2C19 | Procainamide Hydrochloride | NA | NA | NA | NA | 100835 | NA | PubChem |
| CYP2C19 | (E)-Ethyl 3-(6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)acrylate | NA | 166000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | Miristalkonium chloride | NA | NA | NA | NA | 19952600 | NA | PubChem |
| CYP2C19 | 5-Pyridin-3-yl-furan-2-carbaldehyde oxime | NA | 118000|175000|279000 | NA | NA | NA | NA | BindingDB |
| CYP2C19 | 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | NA | 200000 | NA | NA | NA | NA | PubChem |
| CYP2C8 | 2,2-Dimethylbutyric acid | NA | 10000000 | NA | NA | NA | NA | PubChem |
| CYP2C8 | Fluoxetine | 294000 | NA | NA | NA | NA | NA | PubChem |